Emerging Research

Will Hodgkin Lymphoma Patients Benefit From Checkpoint Inhibitors?

Do checkpoint inhibitors have a role in Hodgkin lymphoma care as a frontline treatment? Watach as Dr. Andrew Evens and Dr. Joshua Brody discuss the latest research developments, immunotherapy and more.

Joshua Brody, MD, Andrew Evens, DO, MSc, FACP, Andrew Schorr

Emerging Research

Treatment Developments and Ongoing Hodgkin Lymphoma Research

Expert Dr. John Burke discusses what’s new in the world of Hodgkin lymphoma. Watch now to learn about new studies on the use of radiation, how to treat early stage patients, and more.

Beth Kart Probert, John Burke, MD

Upcoming Events

See all events

Apr 1 2020

Wednesday, April 1, 2020

Coronavirus: Lymphoma Ask the Expert LIVE

Join us as we talk to lymphoma and leukemia expert Dr. Joshua Brody about issues and concerns that could impact lymphoma and leukemia patients during this pandemic.

Topic Area: Hodgkin Lymphoma, Mantle Cell Lymphoma, Non-Hodgkin Lymphoma

Type: Online

Time: 10:00 AM – 10:30 AM Pacific Time (US and Canada)

Learn More

Latest News

Emerging Research

Emerging Research

Will Hodgkin Lymphoma Patients Benefit From Checkpoint Inhibitors?

Joshua Brody, MD, Andrew Evens, DO, MSc, FACP, Andrew Schorr

Treatment Developments and Ongoing Hodgkin Lymphoma Research

Beth Kart Probert, John Burke, MD

Upcoming Events

Wednesday, April 1, 2020

Coronavirus: Lymphoma Ask the Expert LIVE

Latest News

Treatment for Newly Diagnosed Hodgkin Lymphoma

Sairah Ahmed, MD, Esther Schorr

Immunotherapy for Hodgkin Lymphoma

Joshua Brody, MD, Esther Schorr, Andrew Evens, DO, MSc, FACP, Andrew Schorr

Updates in Hodgkin Lymphoma from Dr. Burke

John Burke, MD

Expert Updates in Hodgkin Lymphoma From ASH 2018

Radhakrishnan Ramchandren, MD

Knowledge is power.

Subscribe to e-newsletter(s) to receive emerging research and community updates right to your inbox.

Don't miss a beat.

Cancer Types

Living Well

Navigating Cancer

Patient Power Community

Events

About Us